Clinical Trial Update: A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the effectiveness of DT-101 in patients with Major Depressive Disorder is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• DT-101

Snippet

Sponsor: Draig Therapeutics Ltd | Conditions: Major Depressive Disorder (MDD) | Phase 2 | Status: RECRUITING